Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BalanceD-HF
NCT06307652Phase 3Recruiting
- Sponsor
- AstraZeneca
- Start
- Apr 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 39
01
Overview
A Phase 3 trial of balcinrenone in heart failure (HF), Renal Insufficiency (RI), sponsored by AstraZeneca. Started Apr 2024; status: recruiting.
02
Drugs
balcinrenone
03
Conditions
heart failure (HF)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NCT06307652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06307652.